References | First author’s name | Year of publication | Country of origin | Cancer type | Ethnicity | SNPs | Source of control groups | Matching criteria | Genotyping methods | Case | control | MAF | HWE |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
18 | Rong-rong Liu | 2008 | Hunan, China | ALL | Asian | C3435T,C1236T,G2677T,G2677A | HB | Age, gender, weight | PCR-RFLP | 48 | 100 | 0.17;0.24;0.04 | 0.60;0.21;0.07 |
19 | Zhi-zhuo Du | 2010 | Suzhou, China | ALL | Asian | C3435T,C1236T,G2677T/A | HB | Age, gender | SNP-shot | 176 | 170 | 0.30;0.38;0.27 | 0.00;0.28;0.23 |
2 | Kevin Y. Urayama | 2007 | Northern and Central California, USA | ALL | C3435T,C1236T,G2677T/A | HB | Age, gender, Hispanic status | PCR-SBEP | 294 | 369 | 0.25;0.21;0.18 | 0.30;0.13;0.18 | |
3 | Hiroyoshi Hattori | 2007 | Japan | ALL | Asian | C3435T | HB | Age, gender | Taqman | 622 | 96 | 0.18 | 0.3 |
20 | Jamroziak K | 2004 | Poland | ALL | Caucasian | C3435T | PB | Age, gender, | PCR-RELP | 113 | 175 | 0.24 | 0 |
21 | Evelia Leal-Ugarte | 2008 | Mexico | ALL | C3435T | PB | Gender | PCR-RELP | 107 | 111 | 0.28 | 0.02 | |
22 | A’ gnes F. Semsei | 2008 | Hungary | ALL | Caucasian | C3435T,G2677T/A | PB | Age, gender, risk group | PCR-RELP | 378 | 189 | 0.29;0.28 | 0.07;0.13 |
23 | Vibeke Andersen | 2009 | Danish | colorectal cancer | Caucasian | C3435T,G-rs3789244-A | PB | Age, Gender, | TaqMan | 359 | 765 | 0.33 | 0.47 |
24 | Daniele Campa | 2012 | Czech Republic | colorectal cancer | Caucasian | C3435T | HB | Age, Gender, | Taqman | 699 | 622 | 0.29 | 0.79 |
24 | Daniele Campa | 2012 | Southwest Germany | colorectal cancer | Caucasian | C3435T | HB | Age, Gender, county of residence | Taqman | 1809 | 1853 | 0.28 | 0.91 |
24 | Daniele Campa | 2012 | Southwest Germany | colorectal cancer | Caucasian | C3435T | PB | Age, Gender, | Taqman | 2169 | 1634 | 0.29 | 0.62 |
25 | Urosˇ Potocnik | 2008 | Slovenia | MSI-H colorectal cancer | Caucasian | C3435T,C1236T,G2677T | HB | Age, Gender, | TaqMan | 38 | 355 | 0.30;0.18;0.19 | 0.66;0.33;0.24 |
26 | Nizar M Mhaidat | 2011 | Jordan | HL | Asian | C3435T | HB | Age | PCR-RFLP | 130 | 120 | 0.35 | 0.11 |
27 | Sun-Young Bae | 2006 | Korea | colorectal cancer | Asian | C3435T | HB | Age, Gender, | PCR-RFLP | 111 | 93 | 0.16 | 0.01 |
28 | Azam Khedri | 2011 | Iran | colorectal cancer | Caucasian | C3435T | HB | Age, Gender, | PCR-RFLP | 118 | 137 | 0.35 | 0.56 |
29 | Mateusz Kurzawski | 2005 | Poland | colorectal cancer | Caucasian | C3435T | HB | Age, Gender, | PCR-RFLP | 184 | 188 | 0.29 | 0.27 |
30 | Chiko Komoto | 2006 | Japan | colorectal cancer | Asian | C3435T,C1236T,G2677T | HB | Age, Gender, | TaqMan | 48 | 154 | 0.16;0.375;0.36 | 0.62;0.36;0.37 |
30 | Chiko Komoto | 2006 | Japan | esophageal squamous cell carcinoma | Asian | C3435T,C1236T,G2677T | HB | Age, Gender, | TaqMan | 47 | 154 | 0.17;0.39;0.34 | 0.66;0.34;0.64 |
31 | Bo-In Lee | 2006 | Korea | colorectal cancer | Asian | C3435T | HB | Age, Gender, | PCR-RFLP | 64 | 64 | 0.13 | 0.15 |
32 | Elena Osswald | 2006 | Russia | colorectal cancer | Caucasian | C3435T,G2677T/A | HB | Age, Gender, Smoking intensity | PCR-RFLP | 285 | 275 | 0.26;0.20 | 0.35;0.42 |
33 | Mariusz Panczyk | 2009 | Poland | colorectal cancer | Caucasian | C3435T,C1236T,G2677T | HB | Age, Gender, | PCR-RFLP | 95 | 95 | 0.20;0.17;0.18 | 0.99;0.72;0.60 |
34 | Darinka Todorova Petrova | 2008 | Bulgaria | colorectal cancer | Caucasian | C3435T,G2677T | HB | Age, Gender, | RT-PCR | 146 | 160 | 0.25;0.21 | 0.73;0.32 |
35 | J Sainz | 2011 | South Germany | colorectal cancer | Caucasian | C3435T | PB | Age, Gender, | PCR | 1765 | 1784 | 0.27 | 0.6 |
36 | Cizmarikova | 2010 | Eastern Slovakia | breast cancer | Caucasian | C3435T | PB | Age, Gender, | PCR-RFLP | 221 | 113 | 0.27 | 0.6 |
37 | M. Taheri | 2010 | Iran | breast cancer | Caucasian | C3435T | HB | Age, Gender, | PCR-RFLP | 54 | 50 | 0.26 | 0.61 |
38 | Tatari F | 2009 | North east of Iran | breast cancer | Caucasian | C3435T | HB | Gender, | PCR | 106 | 77 | 0.29 | 0.59 |
39 | Joseph George | 2009 | India | breast cancer | Asian | C3435T | HB | Gender, | PCR | 86 | 68 | 0.15 | 0.7 |
40 | Henriquez-Hernandez | 2009 | Spain | breast cancer | Caucasian | C3435T | HB | Gender, | PCR-RFLP | 135 | 301 | 0.19 | 0.66 |
41 | Nordgard | 2007 | Norway | breast cancer | Caucasian | C3435T,C1236T,G2677T/A | N.A. | Age, Gender, | PCR-RFLP | 109 | 93 | 0.13;0.26;0.26 | 0.27;0.16;0.03 |
42 | Sebahat Turgut | 2007 | Turkey | breast cancer | Caucasian | C3435T | PB | Gender, | PCR-RFLP | 57 | 50 | 0.24 | 0.62 |
43 | Wu H | 2012 | China | breast cancer | Asian | C3435T,C1236T,G2677T/A | PB | Age, Gender, | PCR-RFLP | 1173 | 1244 | 0.17;0.41;0.17 | 0.01;0.04;0.94 |
44 | Z Sabahi | 2010 | Iran | Gastric cancer | Caucasian | C3435T | PB | Age, Gender, | PCR | 48 | 131 | 0.3 | 0.58 |
45 | Mitsushige Sugimoto | 2008 | Japan | Gastric cancer | Asian | C3435T | HB | Age, Gender, | PCR-RFLP | 150 | 168 | 0.17 | 0.68 |
46 | Tomomitsu Tahara | 2006 | Japan | Gastric cancer | Asian | C3435T | HB | Age, Gender, | PCR-RFLP | 157 | 104 | 0.21 | 0.64 |
47 | P.M. MROZIKIEWICZ | 2007 | Poland | endometrial cancer | Caucasian | C3435T | PB | Age, Gender, | PCR | 198 | 488 | 0.26 | 0.61 |
48 | Federica Gemignani | 2007 | six Central and Eastern European countries | lung cancer | Caucasian | C3435T,G2677T/A | HB | Age, Gender, | TaqMan | 299 | 317 | 0.24;0.21 | 0.62;0.01 |
49 | S Haenisch | 2007 | Germany | renal cell cancer | Caucasian | C3435T,G2677T/A | PB | Age, Gender, | PCR-RFLP | 82 | 164 | 0.31;0.22 | 0.58;0.14 |
50 | Krzysztof Jamroziak | 2006 | Poland | AML | Caucasian | C3435T | PB | Age, Gender, | PCR-RFLP | 180 | 180 | 0.23 | 0.64 |
51 | Katie L. Miller | 2005 | USA | Glioma | Caucasian | C3435T | PB | Age, Gender, | PCR-RFLP | 382 | 464 | 0.25 | 0.61 |
52 | Krzysztof Jamroziak | 2006 | Poland | B-cell CLL | Caucasian | C3435T | PB | Age, Gender, | PCR-RFLP | 110 | 201 | 0.2 | 0.65 |
53 | Michael Siegsmund | 2002 | Germany | clear cell renal cell carcinoma (CCRCC) | Caucasian | C3435T | PB | Age, Gender, | PCR-RFLP | 179 | 150 | 0.29 | 0.59 |
53 | Michael Siegsmund | 2002 | Germany | non-CCRCC | Caucasian | C3435T | PB | Age, Gender, | PCR-RFLP | 83 | 150 | 0.3 | 0.58 |
54 | Guillermo Gervasini | 2006 | Spain | lung cancer | Caucasian | C3435T,G2677T/A | PB | Age, Gender, | TaqMan | 96 | 86 | 0.26;0.31 | 0.61;0,。60 |
55 | Soya Sisy Sam | 2007 | India | upper aerodigestive tract (UADT) cancers | Asian | C3435T | HB | Age, Gender, | PCR-RFLP | 219 | 210 | 0.35 | 0.55 |
56 | Krzysztof Jamroziak | 2008 | Poland | multiple myeloma | Caucasian | C3435T,C1236T,G2677T/A | PB | Age, Gender, | PCR-RFLP | 111 | 96 | 0.19;0.15;0.18 | 0.66;0.01;0.55 |
57 | V Rocha | 2008 | France | leukemia | Caucasian | C3435T | PB | Age, Gender, | PCR-RFLP | 107 | 107 | 0.2 | 0.65 |
58 | STEPHEN DRAIN | 2009 | UK | plasma cell myeloma | Caucasian | C3435T | PB | Age, Gender, | PCR-RFLP | 92 | 92 | 0.28 | 0.6 |
59 | G. Penna | 2010 | Italy | B-cell CLL | Caucasian | C3435T,G2677T | PB | Age, Gender, | PCR-RFLP | 125 | 125 | 0.25;0.30 | 0.62;0.00 |
60 | The MARIE-GENICA Consortium | 2010 | Germany | breast cancer | Caucasian | C3435T | PB | Age, Gender, | MALDI-TOFMS | 3148 | 5486 | 0.22 | 0.64 |
61 | HYUN CHANG | 2009 | Korea | Gastric cancer | Asian | C3435T,G2677T/A | PB | Age, Gender, | PCR | 43 | 118 | 0.34;0.23 | 0.56;0.21 |
62 | D Nageswara Rao | 2010 | India | AML | Asian | C3435T | PB | Age, Gender, | PCR-RFLP | 143 | 249 | 0.28 | 0.6 |
62 | D Nageswara Rao | 2010 | India | ALL | Asian | C3435T | PB | Age, Gender, | PCR-RFLP | 147 | 249 | 0.37 | 0.54 |